Capital Purchase of 2 Pyrosequencers
PHE have awarded a Contract to Qiagen Ltd for the capital purchase of two Pyrosequencers. This was a Direct Award under Lot 2 of the PHE Microbiology Framework. Qiagen Ltd are the sole manufacturer and distributor of Pyrosequencers and hold the intellectual property rights to the "sequnecing by sythesis technoloy" (Pyrosequencing).
Buyer
Public Health England
Value
£72,932
Published
15 Feb 2018
Closes
21 Dec 2017
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Other
Category
Goods
Contract starts
15 Feb 2018
Contract ends
15 Feb 2019
CPV classifications
33000000
Medical equipments, pharmaceuticals and personal care products
Lots
Lot default Capital Purchase of 2 Pyrosequencers
£72,932
PHE have awarded a Contract to Qiagen Ltd for the capital purchase of two Pyrosequencers. This was a Direct Award under Lot 2 of the PHE Microbiology Framework. Qiagen Ltd are the sole manufacturer and distributor of Pyrosequencers and hold the intellectual property rights to the "sequnecing by sythesis technoloy" (Pyrosequencing).
Delivery: London · United Kingdom, London, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
15 Feb 2018
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.